$TFX (Teleflex Incorporated)

$TFX {{ '2016-03-17T20:43:05+0000' | timeago}} • Announcement

$TFX said it has entered into separate, privately negotiated agreements with certain of the holders of its 3.875% convertible senior subordinated notes due 2017. $TFX has agreed to exchange $219.2MM of the Notes for cash in an amount equal to $1,000 per $1,000 of Notes.

$TFX {{ '2017-09-05T13:19:54+0000' | timeago}} • Announcement

$TFX agreed to acquire NeoTract. The acquisition is expected to be slightly dilutive to adjusted EPS in 2017, however, $TFX does not expect to adjust its prior adjusted EPS range. During 2018, the acquisition is expected to be breakeven to adjusted EPS, with significant accretion thereafter, including $0.35-0.40 of adjusted EPS accretion in 2019.

$TFX {{ '2017-09-05T13:17:43+0000' | timeago}} • Announcement

$TFX agreed to acquire NeoTract in a transaction valued up to $1.1Bil. The BoDs of both Teleflex and NeoTract have unanimously approved the transaction. During 2017, NeoTract's revenues are expected to be $115-120MM, and anticipates revenues to grow at least 40% in 2018.

$TFX {{ '2017-09-05T13:13:57+0000' | timeago}} • Announcement

$TFX agreed to buy NeoTract Inc. in a transaction valued up to $1.1Bil. $TFX will buy NeoTract for an upfront cash payment of $725MM at closing, and up to an additional $375MM upon the achievement of certain commercial milestones related to sales through the end of 2020. This transaction is expected to close within the next 30 days.

$TFX {{ '2017-08-03T16:09:21+0000' | timeago}} • Announcement

$TFX's BoD declared a quarterly cash dividend of $0.34 per share of common stock. The dividend is payable on Sept. 15, 2017 to shareholders of record on Aug. 15, 2017.

$TFX {{ '2017-07-24T12:12:24+0000' | timeago}} • Announcement

$TFX said its Arrow Seldinger Arterial Catheterization Device received market clearance from the U.S. Food and Drug Administration (FDA). The new Seldinger Arterial Catheterization Device is indicated for short-term use. $TFX expects to launch the Arrow Seldinger Arterial Catheterization Device in US this year.

$TFX {{ '2017-05-15T11:14:58+0000' | timeago}} • Announcement

$TFX commenced the Phase I clinical study of RePlas, a lyophilized fresh frozen plasma product being developed in collaboration with the U.S. Army Medical Materiel Development Activity (USAMMDA). The early administration of plasma has an important role in reducing trauma mortality from uncontrolled bleeding (hemorrhage).

$TFX {{ '2017-05-08T12:46:37+0000' | timeago}} • Announcement

$TFX's BoD declared a quarterly cash dividend of $0.34 per share of common stock. The dividend is payable on June 15, 2017 to shareholders of record at the close of business on May 15, 2017.

$TFX {{ '2017-05-02T14:03:12+0000' | timeago}} • Announcement

$TFX announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its AC3 Optimus Intra-Aortic Balloon Pump (IABP). This device helps a weakened heart pump blood and can deliver IABP therapy to a broad range of patients, even those not previously considered candidates for IABP therapy.

$TFX {{ '2017-04-04T15:08:12+0000' | timeago}} • Announcement

Teleflex Medical Canada Inc., a unit of $TFX, has completed the acquisition of Pyng Medical Corp. Under the terms of the transaction, Pyng shareholders received US$0.302 in cash per common share. Pyng is now wholly-owned by Teleflex Canada.

$TFX {{ '2017-02-23T15:04:46+0000' | timeago}} • Announcement

$TFX's BoD declared a quarterly cash dividend of $0.34 per share of common stock. The dividend is payable on March 15, 2017 to shareholders of record on March 3, 2017.

$TFX {{ '2017-02-23T15:02:08+0000' | timeago}} • Announcement

$TFX said Benson Smith will retire from his position as CEO, effective on Dec. 31, 2017. Smith will continue to serve as its Chairman of the Board. Smith has been nominated to serve for another 3-year term if elected at 2017 annual meeting. Liam Kelly, who now serves as President and COO, will succeed Smith as CEO following his retirement.

$TFX {{ '2017-02-17T18:28:33+0000' | timeago}} • Announcement

$TFX completed its previously announced acquisition of $VASC. On Dec. 2, 2016, the two companies announced a definitive agreement for $TFX to buy all of the issued and outstanding shares of $VASC common stock for $56.00 per share, in cash.

$PGNX {{ '2017-02-16T14:24:33+0000' | timeago}} • Announcement

$PGNX will replace $CLMS in the S&P SmallCap 600 effective Feb. 21, 2017 as $CLMS is being taken private in a transaction expected to be completed soon. $SFLY will replace $VASC in the S&P SmallCap 600 effective Feb. 21, 2017, as $VASC is being acquired by $TFX.

$TFX {{ '2016-12-14T13:37:36+0000' | timeago}} • Announcement

$TFX acquisition of $VASC is currently being investigated by WeissLaw LLP, said $VASC. Ongoing investigation is on the possible breaches of fiduciary duty and other violations of law by $VASC's BoD in connection with the acquisition. Under the terms of agreement, $VASC shareholders will receive $56.00 in cash for each company's share.

$VASC {{ '2016-12-02T14:23:03+0000' | timeago}} • Announcement

$VASC agreed to be acquired by $TFX for purchase price of $56 per share in cash. The transaction implies an equity purchase price of $1Bil. The price is 38.4x the midpoint of preliminary 2017 EPS forecast of $1.44-1.48 and transaction value is 5.2x midpoint of preliminary 2017 revenue forecast of $183-187MM. The deal will close in 1H17.

$TFX {{ '2016-12-02T13:12:02+0000' | timeago}} • Announcement

$TFX acquires $VASC. The transaction is expected to create value for $TFX shareholders and to be accretive to adjusted EPS in 2017, including the impact of incremental interest expense associated with financing the transaction. $TFX expects the acquisition to provide approx. $0.50 in adjusted EPS accretion in FY18.

$TFX {{ '2016-12-02T13:08:40+0000' | timeago}} • Announcement

$TFX acquires $VASC for approx. $1Bil. Under the terms of the agreement, $TFX will acquire all of the issued and outstanding shares of $VASC common stock for $56 per share in cash. The transaction is expected to close during 1H17.

$TFX {{ '2016-10-28T19:19:56+0000' | timeago}} • Announcement

$TFX said that its BoD declared a quarterly cash dividend of $0.34 per share of common stock. The dividend is payable Dec. 15, 2016 to shareholders of record at the close of business on Nov. 15, 2016.

$TFX {{ '2016-10-26T20:24:40+0000' | timeago}} • Webcast

$TFX said its Arrow VPS Rhythm System has been issued CE certification from its notified body, the British Standards Institution (BSI), to commercialize the device in the European Union. The CE mark for the system brings cost-effective catheter navigation and tip confirmation to Europe.

$TFX {{ '2016-10-17T11:36:58+0000' | timeago}} • Announcement

Medical device maker $TFX received FDA clearance to market its Arrow branded midline catheter with Chlorag ard technology. Catheter is a flexible tube inserted through a narrow opening into a body cavity, particularly the bladder, for removing fluid.

Recent Transcripts

MDT (Medtronic plc)
Tuesday, August 22 2017 - 12:00pm
LIVN (LivaNova PLC)
Wednesday, August 9 2017 - 1:00pm
XRAY (DENTSPLY International Inc.)
Wednesday, August 9 2017 - 12:30pm
ATRS (Antares Pharma Inc.)
Tuesday, August 8 2017 - 12:30pm
ENDP (Endo International plc)
Tuesday, August 8 2017 - 12:30pm
VRX (Valeant Pharmaceuticals International, Inc.)
Tuesday, August 8 2017 - 12:00pm
HAE (Haemonetics Corporation)
Monday, August 7 2017 - 12:00pm
AGN (Allergan plc)
Thursday, August 3 2017 - 12:30pm
TFX (Teleflex Incorporated)
Thursday, August 3 2017 - 12:00pm
MASI (Masimo Corporation)
Wednesday, August 2 2017 - 8:30pm
BMRN (BioMarin Pharmaceutical Inc.)
Wednesday, August 2 2017 - 8:30pm
TRXC (TransEnterix, Inc.)
Wednesday, August 2 2017 - 8:30pm
PCRX (Pacira Pharmaceuticals, Inc.)
Wednesday, August 2 2017 - 12:30pm
KTWO (K2M Group Holdings, Inc.)
Tuesday, August 1 2017 - 9:00pm
RMD (ResMed Inc.)
Tuesday, August 1 2017 - 8:30pm
INCY (Incyte Corporation)
Tuesday, August 1 2017 - 2:00pm
IDXX (IDEXX Laboratories, Inc.)
Tuesday, August 1 2017 - 12:30pm
ABBV (AbbVie Inc.)
Friday, July 28 2017 - 1:00pm
HRC (Hill-Rom Holdings, Inc.)
Friday, July 28 2017 - 12:30pm
SYK (Stryker Corporation)
Thursday, July 27 2017 - 8:30pm

AlphaGraphics you may like